Cargando…
Antigen spreading-induced CD8(+)T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells
A key focus in cancer immunotherapy is to investigate the mechanism of efficacious vaccine responses. Using HIV-1 GAG-p24 in a model PD1-based DNA vaccine, we recently reported that vaccine-elicited CD8(+) T cells conferred complete prevention and therapeutic cure of AB1-GAG malignant mesothelioma i...
Autores principales: | Yu, Zhe, Tan, Zhiwu, Lee, Boon Kiat, Tang, Jiansong, Wu, Xilin, Cheung, Ka-Wai, Lok Lo, Nathan Tin, Man, Kwan, Liu, Li, Chen, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741703/ https://www.ncbi.nlm.nih.gov/pubmed/26431275 |
Ejemplares similares
-
Eliminating mesothelioma by AAV-vectored, PD1-based vaccination in the tumor microenvironment
por: Tan, Zhiwu, et al.
Publicado: (2021) -
Tumor suppressor effect of an antibody on xenotransplanted sarcomatoid mesothelioma cells
por: Hasegawa, Masayoshi, et al.
Publicado: (2022) -
Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity
por: David, Jill, et al.
Publicado: (2022) -
Primary Peritoneal Mesothelioma: Diagnostic Challenges of This Lethal Imposter
por: Dusseault, Sonya K., et al.
Publicado: (2022) -
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
por: Srinivasan, Gayathri, et al.
Publicado: (2017)